The posterior probability error-rate estimates (Fukunaga and Kessell 1973; Glick 1978; Hora and Wilcox 1982) for each group are based on the posterior probabilities of the observations classified into ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results